German Government Invests €300M in mRNA Biotech CureVac
The Federal Republic of Germany will invest €300M in CureVac, the homegrown biotech that is…
17/06/2020 - 4 minutes
News and Trends
UK Startup Bags €37M to Remove Cell Therapy Manufacturing Bottleneck
UK biotech startup Bit Bio has received €36.9M in Series A funding to boost the…
16/06/2020 - 3 minutes
Chilean Biotech Moves to France to Develop Anti-Mold Food Preservative
The startup Protera is moving from Santiago de Chile to Paris following a €5M Series…
15/06/2020 - 4 minutes
Novo Nordisk Foundation Commits €100M Grant to Developing Green Tech
The Novo Nordisk Foundation has awarded a five-year grant of €100M to the DTU Biosustain…
15/06/2020 - 3 minutes
AbbVie and Genmab Strike €3.4B Immuno-Oncology Megadeal
AbbVie and Genmab have announced a €3.4B collaboration deal that ranks as the second biggest…
11/06/2020 - 3 minutes
Evox and Lilly Partner to Develop Neuro RNA Drugs in Deal Worth €1.1B
British biotech Evox Therapeutics has signed a collaboration deal worth up to €1.1B with US…
11/06/2020 - 3 minutes
Bavarian Nordic’s Vaccine Shows Biodefense Potential in Phase I
With a successful phase I clinical trial, Danish biotech Bavarian Nordic has come a step…
09/06/2020 - 3 minutes
French Manufacturing Plant Launches to Make Cell Therapy Cheap and Scalable
The Bordeaux-based company Treefrog Therapeutics has opened an industrial demonstration plant with the aim of…
09/06/2020 - 4 minutes
UK Startup Launches with €10M to Detect Epigenetic Signs of Cancer in Blood
A seed round of €10.1M will fund the launch of the University of Oxford spinout…
08/06/2020 - 3 minutes
Boost For Inflammatory Disease Biotech NodThera With €49M Series B
The UK-US biotech NodThera has raised €48.7M in Series B funding to progress its drug…
06/06/2020 - 3 minutes
Upsized Nasdaq IPO Yields Calliditas €80M to Commercialize Kidney Drug
Swedish company Calliditas Therapeutics has raised an €80M IPO on the Nasdaq Global Select Market…
05/06/2020 - 2 minutes
Israeli-Dutch Biotech Raises €55M to Fight Huntington’s Disease and ALS
Prilenia Therapeutics has raised €55M in Series A funding to launch late-stage clinical trials of…
05/06/2020 - 3 minutes
